Gf Fund Management »

Entrada Therapeutics shares owned by Gf Fund Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Gf Fund Management from 13F filings

Historical chart of Gf Fund Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Gf Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Gf Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.7k 807 5.80
2025-06-30 $6.4k 958 6.72
2025-03-31 $8.7k 958 9.04
2024-12-31 $14k 785 17.29

More positions owned by Gf Fund Management

NVIDIA Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOG)
Tesla Common Stock (TSLA)
Alphabet Common Stock (GOOGL)
PDD Holdings Adr (PDD)
Netflix Common Stock (NFLX)
Costco Wholesale Corp Common Stock (COST)
Palantir Technologies Common Stock (PLTR)
Lumentum Holdings Common Stock (LITE)
Advanced Micro Devices Common Stock (AMD)

View all positions for Gf Fund Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
Renaissance Technologies
TCG Crossover Management
State Street Corporation
Dimensional Fund Advisors
Royce & Associates
Citadel Advisors

View all funds holding Entrada Therapeutics